| Literature DB >> 32636615 |
Kamonphat Wongtaweepkij1, Janet Krska2, Juraporn Pongwecharak3, Narumol Jarernsiripornkul1.
Abstract
PURPOSE: Written and electronic medicine information are important for improving patient knowledge and safe use of medicines. Written medicine information in Thailand is mostly in the form of printed package inserts (PIs), designed for health professionals, with few medicines having patient information leaflets (PILs). The aim of this study was to determine practices, needs and expectations of Thai general public about written and electronic medicine information and attitudes towards PILs. PATIENTS AND METHODS: Cross-sectional survey, using self-completed questionnaires, was distributed directly to members of the general public in a large city, during January to March 2019. It explored experiences of using information, expectations, needs and attitudes, the latter measured using a 10-item scale. Differences between sub-groups were assessed, applying the Bonferroni correction to determine statistical significance.Entities:
Keywords: attitudes; general public; medicine information; need and expectations; practices
Year: 2020 PMID: 32636615 PMCID: PMC7335287 DOI: 10.2147/PPA.S257454
Source DB: PubMed Journal: Patient Prefer Adherence ISSN: 1177-889X Impact factor: 2.711
Demographic Characteristics and Practices of Respondents in Relation to Experiences of PILs and Online Medicine Information
| Characteristics and Practices | Total | N (%) | p-valuea | N (%) | p-valuea | ||
|---|---|---|---|---|---|---|---|
| Had | Never Received PILs (n=406) | Had | Never Read Electronic | ||||
Male | 146 (26.5) | 31 (21.5) | 115 (28.3) | 0.112 | 110 (25.5) | 36 (30.5) | 0.271 |
Female | 404 (73.5) | 113 (78.5) | 291 (71.7) | 322 (74.5) | 82 (69.5) | ||
18–44 | 285 (51.8) | 82 (56.9) | 203 (50.0) | 0.348 | 233 (53.9) | 52 (44.1) | 0.016 |
45–60 | 176 (32.0) | 42 (29.2) | 134 (33.0) | 139 (32.2) | 37 (31.4) | ||
>60 | 89 (16.2) | 20 (13.9) | 69 (17.0) | 60 (13.9) | 29 (24.6) | ||
Junior high school and lower | 164 (29.8) | 23 (16.0) | 141 (34.7) | 104 (24.1) | 60 (50.8) | ||
Senior high school and diploma | 172 (31.3) | 36 (25.0) | 136 (33.5) | 138 (31.9) | 34 (28.8) | ||
Bachelor’s degree and higher | 214 (38.9) | 85 (59.0) | 129 (31.8) | 190 (44.0) | 24 (20.3) | ||
≤10,000 baht | 246 (44.7) | 34 (23.6) | 212 (52.2) | 172 (39.8) | 74 (62.7) | ||
>10,000 baht | 304 (55.3) | 110 (76.4) | 194 (47.8) | 260 (60.2) | 44 (37.3) | ||
Always | 296 (61.1) | 114 (56.7) | 182 (64.3) | 244 (61.6) | 52 (59.1) | 0.376 | |
Sometimes | 117 (24.2) | 87 (43.3) | 30 (10.6) | 98 (24.8) | 19 (21.6) | ||
Neverb | 71 (14.7) | 0 (0.0) | 71 (25.1) | 54 (13.6) | 17 (19.3) | ||
At the first time of receiving | 335 (81.1) | 113 (78.5) | 222 (82.5) | 0.577 | 278 (81.3) | 57 (80.3) | 0.941 |
Read when having some questions | 59 (14.3) | 24 (16.6) | 35 (13.0) | 48 (14.0) | 11 (15.5) | ||
Read when adverse symptom happens and others | 19 (4.6) | 7 (4.9) | 12 (4.5) | 16 (4.7) | 3 (4.2) | ||
Always | 144 (34.9) | 64 (44.4) | 80 (29.7) | 0.008 | 118 (34.5) | 26 (36.6) | 0.509 |
Sometimes | 203 (49.1) | 63 (43.8) | 140 (52.1) | 172 (50.3) | 31 (43.7) | ||
Never | 66 (16.0) | 17 (11.8) | 49 (18.2) | 52 (15.2) | 14 (19.7) | ||
Worried | 53 (12.8) | 17 (11.8) | 36 (13.4) | 0.741 | 45 (13.2) | 8 (11.3) | 0.014 |
More confident to use medicine | 318 (77.0) | 114 (79.2) | 204 (75.8) | 269 (78.6) | 49 (69.0) | ||
Othersc | 42 (10.2) | 13 (9.0) | 29 (10.8) | 28 (8.2) | 14 (19.7) | ||
Notes: aPearson Chi-Square test was used to determine differences between groups; p<0.05 with Bonferroni correction (p<0.0015). bReason of never reading medicine leaflet: Had received enough information from doctors (n=38), pharmacists (n=40), have other sources of information (n=9), information from package inserts is not reliable (n=1). cNot confident to use medicine (n=6), not sure (n=25), hesitate to use medicines (n=1), indifferent (n=3), not identified (n=7). Bold numbers of p-value indicate statistical significance at p<0.05.
Abbreviations: PILs, patient information leaflets; N, number of respondents.
Sources of Written and Electronic Medicine Information That Respondents Had Ever Received or Searched
| Sources of Information | N (%) |
|---|---|
PIs | 486 (94.4) |
Labels on the envelopes | 282 (54.8) |
Booklets | 167 (32.4) |
PILs | 144 (28.0) |
Books | 95 (18.4) |
Supplementary labels added by pharmacists | 90 (17.5) |
Newspapers | 90 (17.5) |
Websites | 238 (55.1) |
Television | 208 (48.1) |
| 164 (38.0) | |
Application | 117 (27.1) |
Chat program | 81 (18.8) |
QR code | 34 (7.9) |
Othera | 24 (5.6) |
| 13 (3.0) |
Note: aSearch engine such as Google (n=18), Youtube (n=5), not report (n=1).
Abbreviations: PIs, package inserts; PILs, patient information leaflets; N, number of respondents.
Content of PIs Usually Read and Content of PILs Perceived as Necessary
| Indications | 347 (84.2) | 464 (84.4) |
| Drug name | 303 (73.5) | 427 (77.6) |
| Precautions | 292 (70.9) | 406 (73.8) |
| Directions | 288 (69.9) | 350 (63.6) |
| Possible side effects | 84 (20.4) | 299 (54.5) |
| Contraindications | 193 (46.8) | 241 (43.8) |
| Active ingredients | 102 (24.8) | 136 (24.7) |
| Interactions with other drugs, food, and herbs | 217 (52.7) | 103 (18.7) |
| What to do if side effects happen | 101 (24.5) | 109 (19.9) |
| What to do if you overdose | 61 (14.8) | 99 (18.0) |
| Storage | 188 (45.6) | 83 (15.1) |
| What to do if the dose is missed | 83 (20.1) | 76 (13.8) |
| What to do while you are taking the drug | 190 (46.1) | – |
| Othersa | 4 (1.0) | – |
Notes: aExpiry date (n=3), drug allergy (n=1).
Abbreviations: PIs, package inserts; PILs, patient information leaflets.
Expectations of Medicine Information in Relation to Receiving PILs and Accessing Electronic Medicine Information
| Expectation | Total (N=550) | N (%) | p-valuea | N (%) | p-valuea | ||
|---|---|---|---|---|---|---|---|
| Had Received PILs (n=144) | Never Received PILs (n=406) | Had Read Electronic Medicine Information (n=432) | Never Read Electronic Medicine Information (n=118) | ||||
Yes | 206 (37.5) | 144 (100.0) | 62 (15.3) | 180 (41.7) | 26 (22.0) | ||
No | 344 (62.5) | 0 (0.0) | 344 (84.7) | 252 (58.3) | 92 (78.0) | ||
Useful | 487 (88.5) | 140 (97.2) | 137 (85.5) | 397 (91.9) | 90 (76.3) | ||
Not useful | 8 (1.5) | 1 (0.7) | 7 (1.7) | 1 (0.2) | 7 (5.9) | ||
Not sure | 55 (10.0) | 3 (2.1) | 52 (12.8) | 34 (7.9) | 21 (17.8) | ||
With the first dose | 261 (47.5) | 79 (54.9) | 182 (44.8) | 0.038 | 195 (45.1) | 66 (55.9) | 0.037 |
Every time receiving a medicine | 289 (52.5) | 65 (45.1) | 224 (55.2) | 237 (54.9) | 52 (44.1) | ||
Yes | 461 (83.8) | 126 (87.5) | 335 (82.5) | 0.278 | 375 (86.8) | 86 (72.9) | |
No | 10 (1.8) | 1 (0.7) | 9 (2.2) | 6 (1.4) | 4 (3.4) | ||
Not sure | 79 (14.4) | 17 (11.8) | 62 (15.3) | 51 (11.8) | 28 (23.7) | ||
Yes | 527 (95.8) | 142 (98.6) | 385 (94.8) | 0.051 | 419 (97.0) | 108 (91.5) | 0.016 |
No | 23 (4.2) | 2 (1.4) | 21 (5.2) | 13 (3.0) | 10 (8.5) | ||
Unchanged | 383 (69.6) | 117 (81.3) | 266 (65.5) | 315 (72.9) | 68 (57.6) | ||
Decreased | 86 (15.6) | 18 (12.5) | 68 (16.7) | 66 (15.3) | 20 (17.0) | ||
Not sure | 81 (14.7) | 9 (6.3) | 72 (17.7) | 51 (11.8) | 30 (25.4) | ||
First time of receiving medicine | 433 (78.7) | 119 (82.6) | 314 (77.3) | 0.156 | 350 (81.0) | 83 (70.3) | 0.032 |
When side effect occurs | 48 (8.7) | 7 (4.9) | 41 (10.1) | 32 (7.4) | 16 (13.6) | ||
When having a question | 69 (12.6) | 18 (12.5) | 51 (12.6) | 50 (11.6) | 19 (16.1) | ||
Yes | 412 (74.9) | 118 (81.9) | 294 (72.4) | 0.016 | 346 (80.1) | 66 (55.9) | |
No | 20 (3.6) | 7 (4.9) | 13 (3.2) | 9 (2.1) | 11 (9.3) | ||
Not sure | 118 (21.5) | 19 (13.2) | 99 (24.4) | 77 (17.8) | 41 (34.8) | ||
Notes: aPearson Chi-Square test was used to determine differences between groups; p<0.05 with Bonferroni correction (p<0.0015). bFisher’s Exact test. Bold numbers of p-value indicate statistical significance at p<0.05.
Abbreviations: PILs, patient information leaflets; N, number of respondents; FDA, Food and Drug Administration.
Attitudes of Respondents Towards PILs
| Statements | Attitudes (N, %) | Mean ± S.D. | ||||
|---|---|---|---|---|---|---|
| Absolutely | Agree | Not Sure | Disagree | Absolutely | ||
| 1. The PILs will help you use your medication more accurately. | 402 (73.1) | 142 (25.8) | 4 (0.7) | 0 (0.0) | 2 (0.4) | 4.71 ± 0.513 |
| 2. The PILs make you use the medicines more safely. | 312 (56.7) | 202 (36.7) | 28 (5.1) | 3 (0.5) | 5 (0.9) | 4.48 ± 0.703 |
| 3. The PILs are the source of medicine information that is easily access. | 316 (57.5) | 212 (38.5) | 19 (3.5) | 3 (0.5) | 0 (0.0) | 4.53 ± 0.593 |
| 4. The PILs are not the first choice after you have a question about medicine. | 136 (24.7) | 188 (34.2) | 101 (18.4) | 88 (16.0) | 37 (6.7) | 3.54 ± 1.212 |
| 5. The PILs make you feel worried or unconfident to use the medicine. | 79 (14.4) | 98 (17.8) | 98 (17.8) | 201 (36.5) | 74 (13.5) | 2.83 ± 1.277 |
| 6. You do not need for advice from healthcare professionals if the PILs are available. | 98 (17.8) | 83 (15.1) | 69 (12.5) | 196 (35.6) | 104 (18.9) | 2.77 ± 1.389 |
| 7. The PILs should be provided in all marketed medicines. | 317 (57.6) | 190 (34.5) | 34 (6.2) | 7 (1.3) | 2 (0.4) | 4.48 ± 0.703 |
| 8. Reading the PILs is a waste of time for you. | 61 (11.1) | 72 (13.1) | 39 (7.1) | 250 (45.5) | 128 (23.3) | 2.43 ± 1.281 |
| 9. The online form of the PILs should be provided to patients in order to easily access. | 234 (42.5) | 220 (40.0) | 60 (10.9) | 20 (3.6) | 16 (2.9) | 4.16 ± 0.959 |
| 10. The QR codes of the PILs should be attached with the medicine packages in order to read online medicine information conveniently. | 234 (42.5) | 194 (35.3) | 81 (14.7) | 23 (4.2) | 18 (3.3) | 4.10 ± 1.013 |
Abbreviations: PILs, patient information leaflets; S.D., standard deviation; N, number of respondents.